Electroacupuncture for reproductive hormone levels in patients with diminished ovarian reserve: a prospective observational study

Yang Wang, Yanhong Li, Ruixue Chen, Xiaoming Cui, Jinna Yu, Zhishun Liu, Yang Wang, Yanhong Li, Ruixue Chen, Xiaoming Cui, Jinna Yu, Zhishun Liu

Abstract

Background: Effective methods for the treatment of reproductive dysfunction are limited. Previous studies have reported that acupuncture can modulate female hormone levels, improve menstrual disorders, alleviate depression and improve pregnancy rates. However, studies of acupuncture for diminished ovarian reserve (DOR) are lacking.

Objective: To carry out a prospective observational study aimed at assessing the effect of EA on the reproductive hormone levels of patients with DOR seeking fertility support and consider its safety.

Methods: Eligible patients with DOR received EA for 12 weeks: five times a week for 4 weeks followed by three times a week for 8 weeks. The primary outcome was the change in mean follicle-stimulating hormone (FSH) level at week 12. Mean luteinising hormone (LH) and serum oestradiol (E2) levels, FSH/LH ratios and symptom scale scores were simultaneously observed.

Results: Twenty-one patients with DOR were included in the final analysis. Mean FSH levels fell from 19.33±9.47 mIU/mL at baseline to 10.58±6.34 mIU/mL at week 12 and 11.25±6.68 mIU/mL at week 24. Change in mean FSH from baseline was -8.75±11.13 mIU/mL at week 12 (p=0.002) and -8.08±9.56 mIU/mL at week 24 (p=0.001). Mean E2 and LH levels, FSH/LH ratios and irritability scores were improved at weeks 12 and/or 24. Approximately 30% patients reported subjective increases in menstrual volume after treatment.

Conclusions: EA may modulate reproductive hormone levels and the effects seem to persist for at least 12 weeks after treatment with no significant side effects. EA may improve the ovarian reserve of patients with DOR, though further research is needed.

Trial registration number: NCT02229604; Results.

Keywords: COMPLEMENTARY MEDICINE; GYNAECOLOGY.

Conflict of interest statement

Conflicts of Interest: None declared.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Figures

Figure 1
Figure 1
Flow chart of the study.
Figure 2
Figure 2
Serial measurements of serum follicle-stimulating hormone (FSH) and luteinising hormone (LH) obtained by chemiluminescent microparticle immunoassay, over 24 weeks in 21 women with diminished ovarian reserve receiving a 12-week course of EA treatment. **p

References

    1. Levi AJ, Raynault MF, Bergh PA, et al. . Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril 2001;76:666–9. 10.1016/S0015-0282(01)02017-9
    1. Scott RT Jr, Hofmann GE. Prognostic assessment of ovarian reserve. Fertil Steril 1995;63:1–11.
    1. Pal L, Beviacqua K, Zeitlian G, et al. . Implications of diminished ovarian reserve (DOR) extend well beyond reproductive concerns. Menopause 2008;15:1086–94. 10.1097/gme.0b013e3181728467
    1. Lixia C. The clinical and empirical research on the effect of the Zi Gui Huo Xue Yi Jing recipe on the peri-POF period. Guangzhou: Guangzhou University of Chinese Medicine, 2007.
    1. Lixia C, Yanhua L, Xiaoyun L, et al. . Influence of Jianpi Yishen method on the ovarian reserve. Chin J Clin Res 2013;26:73–4.
    1. Cizmeli C, Lobel M, Franasiak J, et al. . Levels and associations among self-esteem, fertility distress, coping and reaction to potentially being a genetic carrier in women with diminished ovarian reserve. Fertil Steril 2013;99:2037–44. 10.1016/j.fertnstert.2013.02.033
    1. Loutradis D, Drakakis P, Vomvolaki E, et al. . Different ovarian stimulation protocols for women with diminished ovarian reserve. J Assist Reprod Genet 2007;24:597–611. 10.1007/s10815-007-9181-2
    1. Narkwichean A, Maalouf W, Campbell BK, et al. . Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reprod Bio Endocrinol 2013;11:44 10.1186/1477-7827-11-44
    1. Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol 2011;9:67 10.1186/1477-7827-9-67
    1. Yingchun Z, Fangyuan L, Lanrong L, et al. . Influence of acupuncture and herbs for ovarian reserve. J Sichuan Tradit Chin Med 2010;28:103–4.
    1. Zhou K, Jiang J, Wu J, et al. . Electroacupuncture modulates reproductive hormone levels in patients with primary ovarian insufficiency: results from a prospective observational study. Evid Based Complement Alternat Med 2013;2013;657234 10.1155/2013/657234
    1. Chen Y, Fang Y, Yang J, et al. . Effect of acupuncture on premature ovarian failure: a pilot study. Evid Based Complement Alternat Med 2014;2014;718675 10.1155/2014/718675
    1. Wen-yang HE. Acupuncture for 15 premature ovarian insufficiency patients. Zhongguo Zhenjiu 2000;7:399.
    1. Gui-e SHA, Wen-min ZHAO, Ren-hai MA. Observation of acupuncture for 76 premature ovarian insufficiency patients. Zhonguo Zhenjiu 1999;34:653–6.
    1. Cohen J, Chabbert-Buffet N Darai E. Diminished ovarian reserve, premature ovarian failure, poor ovarian responder-a plea for universal definitions. J Assist Reprod Genet 2015;32:1709–12. 10.1007/s10815-015-0595-y
    1. Xiao-feng XU, Chun FAN, Guang-qin BAO. , et al. Investigation of the factors related to premature ovarian failure and diminished ovarian reserve. Chin J Evid Based Med 2011;11:400–3.
    1. Stener-Victorin E, Waldenström U, Tägnfors U, et al. . Effects of electro-acupuncture on anovulation in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 2000;79:180–8. 10.1080/j.1600-0412.2000.079003180.x
    1. Gerhard I, Postneek F. Auricular acupuncture in the treatment of female infertility. Gynecol Endocrinol 1992;6:171–81. 10.3109/09513599209015552
    1. Carr D. Somatosensory stimulation and assisted reproduction. Acupunct Med 2015;33:2–6. 10.1136/acupmed-2014-010739
    1. He J, Yang L, Qing Y, et al. . Effects of electroacupuncture on bone mineral density, oestradiol level and osteoprotegerin ligand expression in ovariectomised rabbits. Acupunct Med 2014;32:37–42. 10.1136/acupmed-2012-010271
    1. Stener-Victorin E, Wu X. Effects and mechanisms of acupuncture in the reproductive system. Auton Neurosci 2010;157:46–51. 10.1016/j.autneu.2010.03.006
    1. Stener-Victorin E, Jedel E, Mannerås L. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence. J Neuroendocrinol 2008;20:290–8. 10.1111/j.1365-2826.2007.01634.x
    1. Johansson J, Redman L, Veldhuis PP. et al. Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2013;304:E934–43. 10.1152/ajpendo.00039.2013
    1. Sunay D, Ozdiken M, Arslan H, et al. . The effect of acupuncture on postmenopausal symptoms and reproductive hormones: a sham controlled clinical trial. Acupunct Med 2011;29:27–31. 10.1136/aim.2010.003285
    1. Lejie. Gynecology. Beijing: People's Medical Publishing House, 2008:308.
    1. Johansson J, Redman L, Veldhuis PP. et al. Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2013;304:E934–43. 10.1152/ajpendo.00039.2013
    1. Jedel E, Labrie F, Odén A, et al. . Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. Am J Physiol Endocrinol Metab 2011;300:E37–45. 10.1152/ajpendo.00495.2010
    1. Barad DH, Weghofer A. Gleicher N. Age-apecific levels of basal follicle stimulating hormone assessment of ovarian function. Obstet Gynecol 2007;109;1404–10. 10.1097/01.AOG.0000264065.37661.a0
    1. Gurtcheff SE, Klein NA. . Diminished ovarian reserve and infertility. Clin Obstet Gynecol 2011;54: 4666–67.
    1. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007;24:629–34. 10.1007/s10815-007-9178-x
    1. Barad DH, Weghofer A, Gleicher N. Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril 2009;91(4 Suppl):1553–5. 10.1016/j.fertnstert.2008.09.069

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다